Subsidies for recommended downstream interventions
This list comprises downstream interventions assessed to be clinically and cost-effective. Individuals who have tested positive for a target gene in the Genetic Test List may be recommended for these follow-up downstream interventions.
Downstream Interventions List (As of 1 April 2026)
Apart from the interventions listed below, PHIs can continue to subsidise routine, low-cost investigations which are part of standard of care (e.g. blood tests, urine tests, ECG). These investigations should be conducted according to clinical guidelines.
Clinical indication | Intervention | Clinical criteria | MediSave / MediShield Life Coverage |
Familial Hypercholesterolaemia (FH) | Cholesterol-lowering drugs | Subsidised based on MOH List of Subsidised Drugs.
| MediSave500/700 as part of chronic disease management under the Chronic Disease Management Programme. No MediShield Life coverage. |
